Welcome to LegisLink:
Advocacy Information for The US Oncology Network
In the wake of our nation's passage of historic, comprehensive health care reform legislation, it is now more important than ever for physicians, caregivers, advocates and patients to remain informed and engaged on the issues that could impact community-based cancer care.
The LegisLink Action Center offers up-to-date information pertaining to key cancer care policy issues at the state and federal levels of government and offers information on how to get engaged in advocacy efforts surrounding these important health care decisions to ensure our voices are heard by policymakers.
Stop the Medicare Part B Drug Experiment Ads
Dr. Barry Brooks Testifies Before the Energy and Commerce Committee on Site-Neutral Payments for Oncology
Fox News Features Virginia Cancer Specialists on Site Neutral Payment Policy
View full details
Urge Your Representative to Sign the Congressional Part B Drug Payment Letter!
Congress Needs to Push Back on CMS Proposed Mandatory Part B Drug Payment Model
On March 8, CMS released a proposed rule outlining a two-phase mandatory demonstration project that would modify drug reimbursement based on geographic areas. In Phase 1, Medicare seeks to adjust the ASP + 6% reimbursement to ASP + 2.5% plus a flat fee of $16.80. In the second Phase, Medicare would implement value-based purchasing tools, contrived by CMS, in conjunction with the Phase 1 variation of the ASP adjustment.
The proposed rule will have a serious impact on community-based cancer clinics and will push cancer patients into the more expensive hospital based setting. This will result in significant differences in the cost and quality of cancer care Medicare patients receive based solely on their zip code.
It's time for Congress to stand up for cancer patients. Urge your Representative to join the Congressional sign on letter led by Congressmen Charles Boustany, Tom Price and John Shimkus asking CMS to withdraw the proposed Medicare Part B drug experiment.
To contact your Member of Congress, CLICK HERE
To view a one-page talking points memo, CLICK HERE.
To view the proposed rule CLICK HERE
Click here to Take Action!